102 related articles for article (PubMed ID: 1782801)
1. Production of platelet-activating factor in photocoagulated retinas.
Dharma S; Bazan HE; Peyman GA; Atef MS
Curr Eye Res; 1991 Nov; 10(11):1031-5. PubMed ID: 1782801
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of platelet activating factor by ocular tissue from inflamed eyes.
Rosenbaum JT; Boney RS; Samples JR; Valone FH
Arch Ophthalmol; 1991 Mar; 109(3):410-3. PubMed ID: 2003804
[TBL] [Abstract][Full Text] [Related]
3. Short-term and long-term role of platelet activating factor as a mediator of in vivo platelet aggregation.
Golino P; Ambrosio G; Ragni M; Pascucci I; Triggiani M; Oriente A; McNatt J; Buja LM; Condorelli M; Chiariello M
Circulation; 1993 Sep; 88(3):1205-14. PubMed ID: 8353882
[TBL] [Abstract][Full Text] [Related]
4. Modulation of platelet-activating-factor production by incorporation of naturally occurring 1-O-alkylglycerols in phospholipids of human leukemic monocyte-like THP-1 cells.
Hichami A; Duroudier V; Leblais V; Vernhet L; Le Goffic F; Ninio E; Legrand A
Eur J Biochem; 1997 Dec; 250(2):242-8. PubMed ID: 9428670
[TBL] [Abstract][Full Text] [Related]
5. A Penicillium sp. F33 metabolite and its synthetic derivatives inhibit acetyl-CoA:1-O-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and carrageenan-induced paw edema in mice.
Yamazaki Y; Yasuda K; Matsuyama T; Ishihara T; Higa R; Sawairi T; Yamaguchi M; Egi M; Akai S; Miyase T; Ikari A; Miwa M; Sugatani J
Biochem Pharmacol; 2013 Sep; 86(5):632-44. PubMed ID: 23817078
[TBL] [Abstract][Full Text] [Related]
6. Measurement of platelet-activating factor in a canine model of coronary thrombosis and in endarterectomy samples from patients with advanced coronary artery disease.
Mueller HW; Haught CA; McNatt JM; Cui K; Gaskell SJ; Johnston DA; Willerson JT
Circ Res; 1995 Jul; 77(1):54-63. PubMed ID: 7788882
[TBL] [Abstract][Full Text] [Related]
7. Tea polyphenols inhibit acetyl-CoA:1-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and platelet-activating factor-induced platelet aggregation.
Sugatani J; Fukazawa N; Ujihara K; Yoshinari K; Abe I; Noguchi H; Miwa M
Int Arch Allergy Immunol; 2004 May; 134(1):17-28. PubMed ID: 15051936
[TBL] [Abstract][Full Text] [Related]
8. Factors that influence the proportions of platelet-activating factor and 1-acyl-2-acetyl-sn-glycero-3-phosphocholine synthesized by the mast cell.
Triggiani M; Fonteh AN; Chilton FH
Biochem J; 1992 Sep; 286 ( Pt 2)(Pt 2):497-503. PubMed ID: 1530582
[TBL] [Abstract][Full Text] [Related]
9. Production of platelet-activating factor in glomeruli and cultured glomerular mesangial cells.
Schlondorff D; Goldwasser P; Neuwirth R; Satriano JA; Clay KL
Am J Physiol; 1986 Jun; 250(6 Pt 2):F1123-7. PubMed ID: 3087218
[TBL] [Abstract][Full Text] [Related]
10. [Production of PAF (1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in the chick retina during embryogenesis].
Bussolino F
Ann Ist Super Sanita; 1988; 24(4):535-7. PubMed ID: 3218801
[No Abstract] [Full Text] [Related]
11. Differences in the acyl composition of the platelet-activating factor (PAF) precursor and other choline phosphoglycerides of the rabbit retinal rod outer segments and neural retina.
Bazan HE; Hurst JS; Bazan NG
Curr Eye Res; 1994 Jan; 13(1):45-50. PubMed ID: 8156825
[TBL] [Abstract][Full Text] [Related]
12. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets.
Suzuki M; Sugatani J; Ino M; Shimura M; Akiyama M; Yamazaki R; Suzuki Y; Miwa M
Am J Physiol; 1998 Jan; 274(1):C47-57. PubMed ID: 9458712
[TBL] [Abstract][Full Text] [Related]
13. Biological effect of orally active platelet-activating factor receptor antagonist SM-10661.
Komuro Y; Imanishi N; Uchida M; Morooka S
Mol Pharmacol; 1990 Sep; 38(3):378-84. PubMed ID: 2402227
[TBL] [Abstract][Full Text] [Related]
14. Production and characterization of specific antibodies against 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (a potent hypotensive and platelet-activating ether-linked phospholipid).
Nishihira J; Ishibashi T; Imai Y
J Biochem; 1984 May; 95(5):1247-51. PubMed ID: 6430883
[TBL] [Abstract][Full Text] [Related]
15. Platelet-activating factor (PAF) accumulation correlates with injury in the cornea.
Bazan HE; Reddy ST; Lin N
Exp Eye Res; 1991 Apr; 52(4):481-91. PubMed ID: 2037028
[TBL] [Abstract][Full Text] [Related]
16. Platelet-aggregating effects of platelet-activating factor-like phospholipids formed by oxidation of phosphatidylcholines containing an sn-2-polyunsaturated fatty acyl group.
Tanaka T; Iimori M; Tsukatani H; Tokumura A
Biochim Biophys Acta; 1994 Jan; 1210(2):202-8. PubMed ID: 8280771
[TBL] [Abstract][Full Text] [Related]
17. Intravitreally injected platelet activating factor induces retinitis in experimental animals.
Rosenbaum JT; Angell E; Wilson D; Broquet C; Boney RS; Braquet P
Curr Eye Res; 1999 May; 18(5):342-8. PubMed ID: 10372995
[TBL] [Abstract][Full Text] [Related]
18. The enantiomer and the positional isomer of platelet-activating factor.
Tence M; Coëffier E; Polonsky J; Benveniste J
Biochim Biophys Acta; 1983 Feb; 755(3):526-30. PubMed ID: 6824744
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and 1-alkyl-2-acetyl-sn-glycerol by human endothelial cells.
Blank ML; Spector AA; Kaduce TL; Lee TC; Snyder F
Biochim Biophys Acta; 1986 May; 876(3):373-8. PubMed ID: 3707974
[TBL] [Abstract][Full Text] [Related]
20. Biosynthesis of paf-acether factor-acether by human skin fibroblasts in vitro.
Michel L; Denizot Y; Thomas Y; Jean-Louis F; Pitton C; Benveniste J; Dubertret L
J Immunol; 1988 Aug; 141(3):948-53. PubMed ID: 3397536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
